Koyfin Home > Directory > Health Care > Antares Pharma > Cost of Goods Sold

Antares Pharma Cost of Goods Sold Chart (ATRS)

Antares Pharma annual/quarterly Cost of Goods Sold from 2001 to 2018.
  • Antares Pharma Cost of Goods Sold for the quarter ending December 12, 2018 was $10m a 25.38% increase of 2m year over year
  • Antares Pharma Cost of Goods Sold for the last 12 months ending December 12, 2018 was $31m a 8.47% increase of 3m year over year
  • Antares Pharma Annual Cost of Goods Sold for 2018 was $31m a 11.59% increase of 4m from 2017
  • Antares Pharma Annual Cost of Goods Sold for 2017 was $27m a -4.92% decrease of -1m from 2016
  • Antares Pharma Annual Cost of Goods Sold for 2016 was $29m a 32.48% increase of 9m from 2015
Other Income Statement Metrics:
  • Antares Pharma EBITDA for the quarter ending December 12, 2018 was $-5m a 1.88% decrease of 0m year over year
  • Antares Pharma Net Income for the quarter ending December 12, 2018 was $6m a 200.96% increase of 12m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Cost of Goods Sold Data

12/2018$10m
09/2018$7m
06/2018$7m
03/2018$7m
12/2017$7m
09/2017$9m
06/2017$6m
03/2017$6m
12/2016$7m
09/2016$8m

Annual ATRS Cost of Goods Sold Data

2018$31m
2017$27m
2016$29m
2015$19m
2014$11m
2013$9m
2012$10m
2011$7m
2010$4m
2009$4m